MT Genex Corporation (9820) AI Stock Analysis

• Market Cap: ¥3.79B
• Dividend Yield: 1.14%
• Average Volume (3M): 926.00
• Price to Earnings (P/E): 14.6
• Beta (1Y): 0.12
• Revenue Growth: 14.46%
• EPS Growth: 12.86%
• Country: JP
• Employees: 134
• Sector: Industrials
• Sector Strength: 72
• Industry: Specialty Business Services
• EPS (TTM): 61.66
• Shares Outstanding: 1,079,600
• 10 Day Avg. Volume: 840
• 30 Day Avg. Volume: 926
• PEG Ratio: -2.33
• Price to Book (P/B): 0.65
• Price to Sales (P/S): 0.68
• P/FCF Ratio: 9.73
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 80 Outperform
• Price Target: ¥4,077.00 ▲(16.49% Upside)

MT Genex Corporation scores highly due to its strong financial performance and positive technical indicators. The valuation is reasonable, supporting a solid overall stock score. The absence of earnings call data and corporate events does not detract from the company's strong fundamentals and market momentum.

Positive Factors

Revenue Growth

Consistent revenue growth indicates a robust market position and effective product offerings, enhancing long-term business sustainability.

Balance Sheet Health

A strong balance sheet with low leverage provides financial stability and flexibility, supporting future growth and investment opportunities.

Operational Efficiency

Healthy EBIT and EBITDA margins demonstrate effective cost management and operational efficiency, contributing to sustained profitability.

Negative Factors

Net Profit Margin Pressure

Decreasing net profit margins could indicate rising costs or pricing pressures, potentially impacting long-term profitability if not addressed.

Cash Generation Challenges

Challenges in converting net income to free cash flow may limit the company's ability to fund growth initiatives and return capital to shareholders.

Employee Base

A relatively small employee base might limit the company's capacity to scale operations quickly in response to market opportunities.

MT Genex Corporation Business Overview & Revenue Model

Company Description

MT Genex Corporation, together with its subsidiaries, operates as a contractor for construction and renovation of houses and office buildings in Japan. It operates through four segments: Renewal, Parking, Facilities Maintenance Management, and Insurance Agency. The company undertakes interior and external construction and renewal work for buildings and residences, as well as provides design and construction supervision for real estate properties. It is also involved in the operation, management, and lease of parking lots; and operation and management of real estate properties. In addition, the company plans and proposes risk management plans, such as various non-life insurance solutions. Further, it engages in the provision of real estate development; hotel management; and maintenance works for electrical equipment systems. The company was founded in 1945 and is headquartered in Tokyo, Japan. MT Genex Corporation operates as a subsidiary of Mori Trust Co., Ltd.

How the Company Makes Money

MT Genex Corporation generates revenue through multiple streams, primarily by selling its proprietary hardware and software solutions to businesses and telecom operators. The company offers subscription-based services for its cloud solutions, which provide ongoing revenue as clients rely on these services for their operational needs. Additionally, MT Genex enhances its earnings through strategic partnerships with other tech firms, enabling collaborative product developments and access to new markets. Maintenance contracts and consulting services also contribute to its revenue, as businesses often seek expert guidance for implementing and optimizing the company's technologies.

MT Genex Corporation Financial Statement Overview

Summary

MT Genex Corporation presents a strong financial position with consistent revenue growth, efficient operations, and a robust balance sheet. Minor challenges exist in net profit margins and cash generation, but overall financial health is solid.

Income Statement

MT Genex Corporation has demonstrated strong revenue growth over the years, with a notable increase from 2024 to 2025. The gross profit margin remains robust, indicating effective cost management. However, the net profit margin has slightly decreased, suggesting some pressure on net earnings. EBIT and EBITDA margins are healthy, reflecting operational efficiency.

Balance Sheet

The company maintains a strong balance sheet with a low debt-to-equity ratio, indicating prudent financial leverage. The equity ratio is high, reflecting a solid equity base relative to total assets. Return on equity has shown stability, underscoring consistent profitability and effective use of shareholder funds.

Cash Flow

MT Genex Corporation exhibits positive free cash flow growth, supported by strong operating cash flows. The operating cash flow to net income ratio suggests efficient conversion of earnings into cash. However, the free cash flow to net income ratio indicates room for improvement in cash generation relative to net income.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	4.07B	3.95B	3.79B	3.26B	2.97B	3.01B
Gross Profit	1.01B	1.01B	961.50M	849.46M	805.24M	762.97M
EBITDA	514.22M	518.58M	502.80M	427.79M	387.80M	356.19M
Net Income	271.70M	264.99M	277.57M	241.66M	212.62M	227.47M
Balance Sheet
Total Assets	4.94B	5.12B	5.00B	4.76B	4.59B	4.54B
Cash, Cash Equivalents and Short-Term Investments	2.12B	2.01B	1.84B	1.83B	1.85B	1.53B
Total Debt	95.41M	102.33M	171.23M	181.80M	251.47M	285.15M
Total Liabilities	814.32M	992.69M	1.09B	1.09B	1.11B	1.23B
Stockholders Equity	4.13B	4.13B	3.91B	3.68B	3.48B	3.31B
Cash Flow
Free Cash Flow	0.00	277.26M	257.94M	76.61M	388.92M	339.51M
Operating Cash Flow	0.00	295.30M	288.99M	122.53M	394.85M	341.66M
Investing Cash Flow	0.00	-11.81M	-183.88M	-22.49M	-1.46M	-120.81M
Financing Cash Flow	0.00	-112.00M	-103.12M	-112.62M	-76.72M	-44.98M

MT Genex Corporation Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 3500.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9820, the sentiment is Positive. The current price of 3500 is below the 20-day moving average (MA) of 3501.75, above the 50-day MA of 3479.60, and above the 200-day MA of 3198.02, indicating a bullish trend. The MACD of 9.47 indicates Negative momentum. The RSI at 54.80 is Neutral, neither overbought nor oversold. The STOCH value of 77.87 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9820.

MT Genex Corporation Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
9820	80 Outperform	¥3.79B	14.63	―	1.14%	14.46%	12.86%
7805	77 Outperform	¥3.44B	7.19	―	1.93%	-1.00%	105.56%
3958	70 Outperform	¥3.25B	11.38	―	3.30%	-3.41%	-24.95%
7793	66 Neutral	¥4.12B	12.70	―	2.05%	―	―
7919	66 Neutral	¥3.44B	9.98	―	3.69%	0.62%	-24.08%
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
7916	61 Neutral	¥5.62B	10.35	―	2.72%	-1.30%	―